States seek to lower drug prices by targeting the companies that manage them for health plans

States are stepping up efforts to tackle the rising cost of medications by targeting the large companies that manage prescription coverage for health insurers. These middlemen, known as pharmacy benefit managers, often negotiate drug prices that can be exorbitantly high, leaving consumers and taxpayers to bear the burden. This move highlights a growing frustration with the pharmaceutical industry's pricing strategies and underscores the broader issue of healthcare affordability in the U.S. By focusing on these intermediaries, states aim to push for more transparent and fair pricing practices that ultimately benefit patients and the healthcare system as a whole.